In a surprising unanimous decision, the Supreme Court has invalidated a patent for “a diagnostic method to observe changes in a patient’s body to determine the best drug dosage for certain diseases.”  Read the decision here and watch this space for more analysis and commentary.

In the meantime, check out our video from a debate the CLB hosted in the fall on Prometheus and the Myriad patent case.